Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

L Tang, C Zhang, H He, Z Pan, D Fan, Y He… - OncoTargets and …, 2018 - Taylor & Francis
Background Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …
被引用次数：14 相关文章

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

L Tang, C Zhang, H He, Z Pan, D Fan… - OncoTargets and …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …
[PDF] semanticscholar.org

[PDF][PDF] associations between aBcg2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

Z Pan, D Fan - OncoTargets and Therapy, 2018 - pdfs.semanticscholar.org
Background: Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

L Tang, C Zhang, H He, Z Pan, D Fan, Y He… - OncoTargets and …, 2018 - dovepress.com
Background: Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …

[引用][C] Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

L Tang, C Zhang, H He, Z Pan, D Fan, Y He… - OncoTargets and …, 2018 - cir.nii.ac.jp
Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung
cancer: a meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

L Tang, C Zhang, H He, Z Pan, D Fan, Y He… - OncoTargets and …, 2018 - go.gale.com
Background: Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …
[PDF] scienceopen.com

[PDF][PDF] associations between aBcg2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

Z Pan, D Fan - OncoTargets and Therapy, 2018 - scienceopen.com
Background: Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …
[HTML] nih.gov

[HTML][HTML] Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

L Tang, C Zhang, H He, Z Pan, D Fan, Y He… - OncoTargets and …, 2018 - ncbi.nlm.nih.gov
Background Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis.

L Tang, C Zhang, H He, Z Pan, D Fan, Y He… - Oncotargets and …, 2018 - europepmc.org
Background Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

L Tang, C Zhang, H He, Z Pan, D Fan… - OncoTargets and …, 2018 - search.proquest.com
Background: Gefitinib is frequently used to treat patients with non-small cell lung cancer
(NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2 …